Orbimed Advisors as of March 31, 2026
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 110 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Edgewise Therapeutics (EWTX) | 9.5 | $489M | 16M | 31.50 | |
| Enliven Therapeutics (ELVN) | 6.0 | $312M | 8.0M | 39.20 | |
| Avita Therapeutics (RCEL) | 5.9 | $303M | 82M | 3.70 | |
| Mdxhealth Sa Shs New Call Option (MDXH) | 5.5 | $286M | 124M | 2.30 | |
| Eli Lilly & Co. (LLY) | 4.2 | $218M | 237k | 919.77 | |
| Sinovac Biotech SHS | 3.6 | $185M | 2.7M | 67.85 | |
| Boston Scientific Corporation (BSX) | 2.9 | $150M | 2.4M | 62.75 | |
| Sionna Therapeutics (SION) | 2.7 | $142M | 3.5M | 40.09 | |
| Astrazeneca Ord (AZN) | 2.6 | $132M | 670k | 197.22 | |
| Myriad Genetics (Principal) (MYGN) | 2.4 | $123M | 125M | 0.98 | |
| Mbx Biosciences (MBX) | 2.1 | $109M | 3.6M | 29.85 | |
| Corvus Pharmaceuticals (CRVS) | 2.0 | $105M | 7.2M | 14.63 | |
| Argenx Se Sponsored Adr (ARGX) | 1.9 | $100M | 137k | 730.25 | |
| Edwards Lifesciences (EW) | 1.9 | $99M | 1.2M | 80.08 | |
| Intuitive Surgical Com New (ISRG) | 1.9 | $96M | 209k | 460.99 | |
| Compass Therapeutics (CMPX) | 1.6 | $81M | 15M | 5.29 | |
| Merck & Co (MRK) | 1.5 | $80M | 663k | 120.29 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.4 | $71M | 1.5M | 48.20 | |
| Arrivent Biopharma (AVBP) | 1.4 | $70M | 3.0M | 23.07 | |
| Disc Medicine (IRON) | 1.3 | $68M | 1.1M | 63.94 | |
| Silverback Therapeutics (SPRY) | 1.3 | $67M | 8.3M | 8.03 | |
| Cg Oncology (CGON) | 1.2 | $64M | 948k | 67.68 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $62M | 1.1M | 58.15 | |
| Stryker Corporation (SYK) | 1.2 | $60M | 183k | 328.59 | |
| Bristol Myers Squibb (BMY) | 1.1 | $56M | 925k | 60.65 | |
| Mineralys Therapeutics (MLYS) | 1.1 | $56M | 2.1M | 27.09 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.1 | $56M | 173k | 322.19 | |
| Pfizer (PFE) | 1.1 | $55M | 1.9M | 28.08 | |
| Dyne Therapeutics (DYN) | 1.0 | $53M | 2.9M | 18.13 | |
| Natera (NTRA) | 1.0 | $52M | 262k | 199.99 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.0 | $52M | 466k | 111.35 | |
| Upstream Bio (UPB) | 1.0 | $51M | 5.7M | 9.00 | |
| Danaher Corporation (DHR) | 1.0 | $50M | 266k | 189.60 | |
| Caris Life Sciences (CAI) | 1.0 | $50M | 2.8M | 17.88 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $42M | 182k | 228.73 | |
| Shattuck Labs (STTK) | 0.8 | $41M | 6.3M | 6.43 | |
| Guardant Health (GH) | 0.8 | $40M | 435k | 92.37 | |
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $39M | 119k | 330.87 | |
| Prelude Therapeutics (PRLD) | 0.7 | $37M | 11M | 3.42 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.7 | $36M | 999k | 36.32 | |
| Axsome Therapeutics (AXSM) | 0.7 | $36M | 214k | 169.02 | |
| Uniqure Nv SHS (QURE) | 0.7 | $35M | 2.1M | 16.35 | |
| Oric Pharmaceuticals (ORIC) | 0.7 | $34M | 2.7M | 12.67 | |
| Anthem (ELV) | 0.7 | $34M | 115k | 292.75 | |
| Relmada Therapeutics (RLMD) | 0.6 | $33M | 4.7M | 6.96 | |
| Imagenebio Nonvoting | 0.6 | $31M | 6.2M | 5.00 | |
| Forte Biosciences Com New (FBRX) | 0.6 | $31M | 1.2M | 25.90 | |
| Trevi Therapeutics (TRVI) | 0.6 | $29M | 2.5M | 11.93 | |
| Esperion Therapeutics (ESPR) | 0.6 | $29M | 11M | 2.74 | |
| Neuropace (NPCE) | 0.5 | $28M | 2.1M | 13.15 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $27M | 314k | 86.97 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.4 | $23M | 185k | 124.65 | |
| Thermo Fisher Scientific (TMO) | 0.4 | $23M | 47k | 491.53 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $23M | 962k | 23.36 | |
| Brightspring Health Svcs (BTSG) | 0.4 | $21M | 498k | 42.61 | |
| Lexeo Therapeutics (LXEO) | 0.4 | $21M | 3.6M | 5.74 | |
| Sutro Biopharma Com Shs (STRO) | 0.4 | $20M | 801k | 24.91 | |
| Nektar Therapeutics Com New (NKTR) | 0.4 | $20M | 275k | 71.95 | |
| Cybin Com New (HELP) | 0.4 | $18M | 3.8M | 4.80 | |
| Krystal Biotech (KRYS) | 0.3 | $18M | 69k | 258.32 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $16M | 1.7M | 9.39 | |
| Urogen Pharma (URGN) | 0.3 | $16M | 876k | 17.98 | |
| Definium Therapeutics Com Shs (DFTX) | 0.3 | $15M | 804k | 18.90 | |
| Vera Therapeutics Cl A (VERA) | 0.3 | $15M | 370k | 40.23 | |
| Q32 Bio (QTTB) | 0.3 | $15M | 2.3M | 6.42 | |
| Aadi Bioscience (WHWK) | 0.3 | $14M | 4.2M | 3.45 | |
| Amgen (AMGN) | 0.3 | $14M | 40k | 351.85 | |
| Alignment Healthcare (ALHC) | 0.3 | $14M | 791k | 17.62 | |
| Eyepoint Com New (EYPT) | 0.3 | $14M | 1.1M | 12.89 | |
| Janux Therapeutics (JANX) | 0.3 | $14M | 984k | 13.90 | |
| BioCryst Pharmaceuticals (BCRX) | 0.3 | $14M | 1.4M | 9.52 | |
| Bicara Therapeutics (BCAX) | 0.3 | $13M | 667k | 19.89 | |
| Bioage Labs (BIOA) | 0.2 | $12M | 712k | 17.49 | |
| Cogent Biosciences (COGT) | 0.2 | $12M | 322k | 38.49 | |
| Alumis (ALMS) | 0.2 | $12M | 548k | 22.03 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $11M | 15k | 772.64 | |
| Carlsmed (CARL) | 0.2 | $11M | 1.3M | 9.05 | |
| Biogen Idec (BIIB) | 0.2 | $11M | 62k | 183.33 | |
| Qiagen Nv Ord Shares Call Option (QGEN) | 0.2 | $10M | 250k | 40.04 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.2 | $8.7M | 181k | 48.15 | |
| Keros Therapeutics (KROS) | 0.2 | $8.4M | 759k | 11.04 | |
| Gilead Sciences (GILD) | 0.2 | $8.3M | 60k | 139.37 | |
| Heron Therapeutics (HRTX) | 0.2 | $7.9M | 9.8M | 0.80 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $7.1M | 475k | 14.93 | |
| Tectonic Therapeutic (TECX) | 0.1 | $7.0M | 227k | 30.91 | |
| Adicet Bio Com New (ACET) | 0.1 | $7.0M | 1.0M | 6.81 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $6.4M | 1.2M | 5.53 | |
| Pharvaris N V (PHVS) | 0.1 | $5.8M | 205k | 28.25 | |
| Alx Oncology Hldgs (ALXO) | 0.1 | $5.7M | 2.9M | 2.00 | |
| CryoLife (AORT) | 0.1 | $5.5M | 151k | 36.62 | |
| Inspiremd (NSPR) | 0.1 | $5.1M | 3.1M | 1.63 | |
| Revolution Medicines (RVMD) | 0.1 | $5.1M | 52k | 97.25 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $4.9M | 1.3M | 3.75 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $4.4M | 42k | 105.40 | |
| Palisade Bio (PALI) | 0.1 | $4.1M | 2.3M | 1.75 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $3.8M | 168k | 22.48 | |
| Savara (SVRA) | 0.1 | $3.5M | 635k | 5.46 | |
| Cullinan Oncology (CGEM) | 0.1 | $3.5M | 243k | 14.21 | |
| Soleno Therapeutics Call Option (SLNO) | 0.1 | $3.3M | 100k | 33.48 | |
| Ptc Therapeutics I (PTCT) | 0.1 | $3.3M | 49k | 68.13 | |
| Lifestance Health Group (LFST) | 0.1 | $3.2M | 500k | 6.37 | |
| Bright Minds Biosciences Com New (DRUG) | 0.1 | $2.9M | 40k | 72.97 | |
| Jade Biosciences Com New (JBIO) | 0.1 | $2.6M | 185k | 14.05 | |
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $2.3M | 856k | 2.63 | |
| Kalvista Pharmaceuticals (KALV) | 0.0 | $1.9M | 94k | 20.13 | |
| Imagenebio (IMA) | 0.0 | $1.9M | 379k | 5.00 | |
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $1.7M | 3.1M | 0.57 | |
| Ataibeckley Com Shs (ATAI) | 0.0 | $1.2M | 347k | 3.54 | |
| Cogent Biosciences Note 1.625%11/1 (Principal) | 0.0 | $1.2M | 1.0M | 1.22 | |
| Traws Pharma Com New (TRAW) | 0.0 | $1.1M | 606k | 1.83 |